Basic Information
Basic information for MIR4300HG-204-93aa
Peptide Name MIR4300HG-204-93aa
Genome Position chr11:81821274-81821430,81824876-81824931,82100142-82100207[-]
Species Human
Peptide Sequence MTRENLRLNNNNTLGHCINSIIVLFQAGNITLTREPSSSLVWIVSVNYHSNLNGVVGRRDTLKSKKRGKKCNRYSDTLAEVSIAKYCGAQRKK
Peptide Length 93
Unique No (MIR4300HG-206-93aa)
Grand Average of Hydropathicity -0.5032
Relative Molecular Mass 12122.6
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000245832;MIR4300HG
Transcript ID/Name ENST00000653173;MIR4300HG-204
Transcript Length 934
Coding Ability 0.5257
DNA Sequence Corresponding to Peptide ATGACAAGAGAGAATCTACGTCTCAACAACAACAACACGCTTGGGCACTGTATTAACTCCATAATCGTCCTTTTCCAGGCAGGAAATATAACACTGACCAGAGAACCAAGTTCCTCTCTTGTATGGATTGTTTCTGTTAATTATCACTCAAATCTGAACGGTGTGGTAGGACGGAGGGATACCTTGAAATCTAAGAAAAGGGGAAAAAAGTGCAATCGCTACAGTGATACTTTAGCAGAAGTTTCTATTGCTAAGTATTGTGGAGCTCAGAGGAAGAAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :